Inventor · disambiguated record
Hong Jiang
Also filed as: JIANG HONG · JIANG HONG-JIAN
20 granted patents·25 pending applications·395 citations·filing 1992–2024
92Inventor score
Top patents by PatentIndex Score
45 records- 0196US5568384ABiomedical imaging and analysisMAYO FOUNDATION·Filed 1992·Granted Oct 22, 1996·370 cites·3 claims
- 0291US8911739B2Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptideJIANG HONG·Filed 2010·Granted Dec 16, 2014·6 cites·12 claims
- 0390US9597381B2Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and HLA-E-bearing compositionUNIV COLUMBIA·Filed 2015·Granted Mar 21, 2017·3 cites·12 claims
- 0489US9155787B2Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with type B peptideUNIV COLUMBIA·Filed 2014·Granted Oct 13, 2015·4 cites·13 claims
- 0587US11124562B2Anti-ApoE antibodiesUNIV WASHINGTON·Filed 2017·Granted Sep 21, 2021·3 cites·15 claims
- 0684US2025145697A1Anti-apoe antibodiesWASHINGTON UNIVERSITY ST LOUIS·Filed 2024·Application pending·0 cites
- 0782US2025171745A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2024·Application pending·0 cites
- 0881US9421249B2Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological diseaseUNIV COLUMBIA·Filed 2013·Granted Aug 23, 2016·3 cites·2 claims
- 0978US12076345B2Method for treating multiple sclerosis with peptide-loaded dendritic cellsAVOTRES INC·Filed 2022·Granted Sep 3, 2024·0 cites·7 claims
- 1078US11944646B2Method for treating type I diabetes with peptide-loaded dendritic cellsAVOTRES INC·Filed 2022·Granted Apr 2, 2024·0 cites·15 claims
- 1178US11779607B2Detection of a defect on HLA-E restricted CD8+ T regulatory cellsAVOTRES INC·Filed 2022·Granted Oct 10, 2023·0 cites·7 claims
- 1277US12365901B2Application of mechanical-force sensitive macrophage subset in pancreatic cancer diagnosis or prognosis evaluationJIANG HONG·Filed 2024·Granted Jul 22, 2025·0 cites·3 claims
- 1376US11926660B2Anti-ApoE antibodiesWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Granted Mar 12, 2024·0 cites·8 claims
- 1474US11155599B2Adenoviruses expressing heterologous tumor-associated antigensUNIV TEXAS·Filed 2013·Granted Oct 26, 2021·1 cites·17 claims
- 1574US9834596B2Antibodies to tauUNIV WASHINGTON·Filed 2013·Granted Dec 5, 2017·3 cites·14 claims
- 1673US11090344B2Adenovirus and immunomodulator combination therapyDNATRIX INC·Filed 2017·Granted Aug 17, 2021·1 cites·14 claims
- 1769US6849610B1Polynucleotide ligands as anti-viral agentsUNIV CALIFORNIA·Filed 2000·Granted Feb 1, 2005·1 cites·8 claims
- 1868US2021301264A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2021·Application pending·0 cites
- 1967US2010267622A1Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological diseaseJIANG HONG·Filed 2009·Application pending·0 cites
- 2067US2025242052A1Dna therapeutic encoding an antibody or antigen binding fragmentJIANG HONG·Filed 2023·Application pending·0 cites
- 2166US2024092905A1Dna therapeutic encoding an antibody or antigen binding fragmentAEGIS LIFE INC·Filed 2023·Application pending·0 cites
- 2265US2025090653A1Sars cov-2 vaccine, associated polynucleotides, and methods of useAEGIS LIFE INC·Filed 2022·Application pending·0 cites
- 2364US2021395349A1Anti-tau constructsUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2463US2019389953A1Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological diseaseUNIV COLUMBIA·Filed 2019·Application pending·0 cites
- 2559US2020207843A1Anti-tau constructsUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2658US2016289645A1Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)DNATRIX INC·Filed 2014·Application pending·0 cites
- 2758US2024069038A1Biomarkers composition related to diagnosis and prognosis of immunoglobulin a nephropathy and application thereofUNIV ZHEJIANG·Filed 2022·Application pending·0 cites
- 2857US2025020669A1Methods for detecting neurofilament light chain in plasma and cerebrospinal fluidWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Application pending·0 cites
- 2956US2019093085A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2018·Application pending·0 cites
- 3055US2017058034A1Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological diseaseUNIV COLUMBIA·Filed 2016·Application pending·0 cites
- 3154US12145988B2Anti-TREM-2 agonist antibodiesWASHINGTON UNIVERSITY ST LOUIS·Filed 2019·Granted Nov 19, 2024·0 cites·9 claims
- 3254US2024076705A1Lambda-carrageenase mutant ouc-cgla-dpqq and application thereofOCEAN UNIV CHINA·Filed 2023·Application pending·0 cites
- 3353US2022064271A1Methods for treating tauopathiesUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 3451US2018016328A1Anti-tau constructsUNIV WASHINGTON·Filed 2016·Application pending·0 cites
- 3548US12378276B2Convergent liquid phase syntheses of oligonucleotidesBIOGEN MA INC·Filed 2020·Granted Aug 5, 2025·0 cites·17 claims
- 3647US11912650B2Bakuchiol derivatives, pharmaceutically acceptable salts thereof, and preparation method and use of the sameJIANGXI SHIMEI PHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 27, 2024·0 cites·9 claims
- 3746US12040049B2Directional polymerisation fluorescent probe PCR and test kitJIANG HONG·Filed 2019·Granted Jul 16, 2024·0 cites·10 claims
- 3844US2014037638A1Compositions and methods for treating amyloid plaque associated symptomsHOLTZMAN DAVID·Filed 2011·Application pending·0 cites
- 3944US2016355581A1Compositions and methods for treating amyloid plaque associated symptomsUNIV WASHINGTON·Filed 2016·Application pending·0 cites
- 4043US2018037641A1Antibodies to tauUNIV WASHINGTON·Filed 2017·Application pending·0 cites
- 4141US2012183518A1Assay for determining health of cd8+ t cellsJIANG HONG·Filed 2010·Application pending·0 cites
- 4239US2010209918A1System substitute pcrSYSTEM SUBSTITUTE PCR·Filed 2008·Application pending·0 cites
- 4334US10036062B2Primer middle sequence interference PCR technologyBEIJING TAG ARRAY MOLECULAR TEST CO LTD·Filed 2013·Granted Jul 31, 2018·0 cites·17 claims
- 4425US2003103988A1Regulation of activated t cells by recognition of t cell receptor beta chains and major histocompatibility complex class ib moleculesFiled 1995·Application pending·0 cites
- 4522US2016051582A1Pharmaceutical composition for treatment of chronic painLI QIFANG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hong Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →